(Q40535540)

21 September 2017

Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma (English)

1 reference

21 September 2017

7

Henning Schliephake

1 reference

21 September 2017

Margret Rave-Fränk

1

1 reference

21 September 2017

Narges Tehrany

2

1 reference

21 September 2017

Julia Kitz

3

1 reference

21 September 2017

Martin Leu

4

1 reference

21 September 2017

Hanne Elisabeth Weber

5

1 reference

21 September 2017

Peter Burfeind

6

1 reference

21 September 2017

Martin Canis

8

1 reference

21 September 2017

Tim Beissbarth

9

1 reference

21 September 2017

Holger Michael Reichardt

10

1 reference

21 September 2017

Hendrik Andreas Wolff

11

1 reference

21 September 2017

language of work or name

1 reference

15 September 2015

1 reference

Strahlentherapie und Onkologie

21 September 2017

1 reference

21 September 2017

192

1 reference

21 September 2017

1

1 reference

21 September 2017

47-54

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-015-0892-5

21 September 2017

0 references

cites work

Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

CXC chemokines in cancer angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Halting metastasis through CXCR4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

WHIM syndrome and oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0892-5

Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases

21 January 2018

1 reference

12 December 2020

Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma

1 reference

12 December 2020

Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma

1 reference

12 December 2020

Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.

1 reference

12 December 2020

CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma

1 reference

12 December 2020

Role of Twist in head and neck carcinoma with lymph node metastasis

1 reference

12 December 2020

Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma.

1 reference

12 December 2020

10.1007/S00066-015-0892-5

Identifiers

DOI

1 reference

21 September 2017

1 reference